Gene · 4065
Papers1,798
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,798
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance. | Cells | 2022 | 36291050 | PubTator, text mining | PubMed |
| Strategies to overcome DC dysregulation in the tumor microenvironment. | Front Immunol | 2022 | 36275666 | PubTator, text mining | PubMed |
| How cell migration helps immune sentinels. | Front Cell Dev Biol | 2022 | 36268510 | PubTator, text mining | PubMed |
| CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment. | Technol Cancer Res Treat | 2022 | 36254536 | PubTator, text mining | PubMed |
| Metabolic guidance and stress in tumors modulate antigen-presenting cells. | Oncogenesis | 2022 | 36244976 | PubTator, text mining | PubMed |
| Virus-Associated Nephropathies: A Narrative Review. | Int J Mol Sci | 2022 | 36233315 | PubTator, text mining | PubMed |
| Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy. | Int J Mol Sci | 2022 | 36232698 | PubTator, text mining | PubMed |
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
| Vitamin D, exercise, and immune health in athletes: A narrative review. | Front Immunol | 2022 | 36211340 | PubTator, text mining | PubMed |
| MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy. | Front Pharmacol | 2022 | 36210816 | PubTator, text mining | PubMed |
| Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis. | Front Immunol | 2022 | 36177043 | PubTator, text mining | PubMed |
| Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis. | Sci Rep | 2022 | 36167975 | PubTator, text mining | PubMed |
| Amplifying Dendritic Cell Activation by Bioinspired Nanometal Organic Frameworks for Synergistic Sonoimmunotherapy. | Small | 2022 | 36148843 | PubTator, text mining | PubMed |
| Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses. | Viruses | 2022 | 36146843 | PubTator, text mining | PubMed |
| Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review. | Pharmaceutics | 2022 | 36145531 | PubTator, text mining | PubMed |
| Rebooting Regulatory T Cell and Dendritic Cell Function in Immune-Mediated Inflammatory Diseases: Biomarker and Therapy Discovery under a Multi-Omics Lens. | Biomedicines | 2022 | 36140240 | PubTator, text mining | PubMed |
| Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo. | JCI Insight | 2022 | 36125890 | PubTator, text mining | PubMed |
| Human dendritic cell targeting peptide can be targeted to porcine dendritic cells to improve antigen capture efficiency to stimulate stronger immune response. | Front Immunol | 2022 | 36059519 | PubTator, text mining | PubMed |
| Stem-like T cells and niches: Implications in human health and disease. | Front Immunol | 2022 | 36059484 | PubTator, text mining | PubMed |
| Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems. | Macromolecules | 2022 | 36034324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4065/papers?page=11